GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » HTG Molecular Diagnostics Inc (STU:65H) » Definitions » Shiller PE Ratio

HTG Molecular Diagnostics (STU:65H) Shiller PE Ratio : (As of Jun. 08, 2024)


View and export this data going back to 2017. Start your Free Trial

What is HTG Molecular Diagnostics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


HTG Molecular Diagnostics Shiller PE Ratio Historical Data

The historical data trend for HTG Molecular Diagnostics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HTG Molecular Diagnostics Shiller PE Ratio Chart

HTG Molecular Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HTG Molecular Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HTG Molecular Diagnostics's Shiller PE Ratio

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HTG Molecular Diagnostics's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's Shiller PE Ratio falls into.



HTG Molecular Diagnostics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

HTG Molecular Diagnostics's E10 for the quarter that ended in Mar. 2023 is calculated as:

For example, HTG Molecular Diagnostics's adjusted earnings per share data for the three months ended in Mar. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-2.13/127.3478*127.3478
=-2.130

Current CPI (Mar. 2023) = 127.3478.

HTG Molecular Diagnostics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 0.000 96.871 0.000
201309 0.000 98.790 0.000
201312 -1,304.933 98.326 -1,690.097
201403 -1,421.830 99.695 -1,816.218
201406 -1,901.552 100.560 -2,408.111
201409 -1,784.521 100.428 -2,262.868
201412 -2,220.185 99.070 -2,853.907
201503 -123.440 99.621 -157.796
201506 -277.456 100.684 -350.934
201509 -121.888 100.392 -154.616
201512 -137.148 99.792 -175.018
201603 -164.872 100.470 -208.978
201606 -156.995 101.688 -196.611
201609 -147.549 101.861 -184.467
201612 -129.685 101.863 -162.131
201703 -122.858 102.862 -152.103
201706 -96.119 103.349 -118.439
201709 -69.469 104.136 -84.954
201712 -22.815 104.011 -27.934
201803 -32.115 105.290 -38.843
201806 -21.571 106.317 -25.838
201809 -26.224 106.507 -31.355
201812 -11.075 105.998 -13.306
201903 -30.267 107.251 -35.939
201906 -27.081 108.070 -31.912
201909 -24.516 108.329 -28.820
201912 -12.241 108.420 -14.378
202003 -13.792 108.902 -16.128
202006 -13.853 108.767 -16.219
202009 -11.411 109.815 -13.233
202012 -8.187 109.897 -9.487
202103 -8.064 111.754 -9.189
202106 -3.884 114.631 -4.315
202109 -6.120 115.734 -6.734
202112 -7.346 117.630 -7.953
202203 -8.835 121.301 -9.275
202206 -6.130 125.017 -6.244
202209 -4.969 125.227 -5.053
202212 -3.889 125.222 -3.955
202303 -2.130 127.348 -2.130

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


HTG Molecular Diagnostics  (STU:65H) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


HTG Molecular Diagnostics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of HTG Molecular Diagnostics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HTG Molecular Diagnostics (STU:65H) Business Description

Traded in Other Exchanges
Address
3430 E. Global Loop, Tucson, AZ, USA, 85706
HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.

HTG Molecular Diagnostics (STU:65H) Headlines

No Headlines